Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

6 677 evidences · page 198 / 268

52,5 %Infections in Kilifi were mostly monoclonal (52.5%) with a mean complexity of infection (COI) of 1.7.

Kenyapaludismeobservé 2020publié 2025Malaria journalPubMeddocument de 4 observations

53,7 %The negative predictive value of microscopy for detecting P. falciparum parasitaemia was 53.7% in asymptomatic children aged 7–14 years in western Kenya.

Kenyapaludismepublié 2022Malaria journalPubMeddocument de 6 observations

64 %Overall 2-dose effectiveness of monovalent rotavirus vaccine (RV1) was 64% (95% confidence interval [CI], 35%-80%).

Kenyarotavirusobservé July 2014 to December 2017publié 2020Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 2 observations

0,85 aHRClinical decision support systems were marginally associated with reduced time from enrollment to first documentation of loss to follow-up, with an adjusted hazard ratio of 0.85.

KenyaVIH/sidaobservé between Sept 1, 2012 and Jan 31, 2014publié 2021BMC medical informatics and decision makingPubMeddocument de 5 observations

8 %The prevalence of confirmed tuberculosis was 8% among 168 hospitalized antiretroviral therapy-naive Kenyan children with HIV.

Kenyatuberculosepublié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 5 observations

10 %Among African adolescent girls and young women enrolled in the POWER study, 10% had gonorrhoea.

Kenyagonorrhoeapublié 2022Journal of the International AIDS SocietyPubMeddocument de 12 observations

HAdV-F40 and HAdV-F41 co-circulated throughout the study period in coastal Kenya.

KenyaHuman enteric adenovirus species Fobservé 2013 and 2022publié 2023Virus evolutioneurope_pmcdocument de 5 observationsDOI 10.1093/ve/vead023

0 participantsNo participants had virological failure in the oral therapy group.

KenyaVIH/sidapublié 2024The Lancet. Infectious diseasesPubMeddocument de 10 observations

20,8 %Of the alleles detected, 211 (20.8%) were RO33.

Kenyapaludismepublié 2023Malaria journalPubMeddocument de 5 observations

1,106 odds_ratioThe odds of being virally suppressed were increased by IL-10 (OR = 1.106, 95% CI: 0.675–1.811) in HIV-1 participants on first-line cART.

KenyaVIH/sidapublié 2025The Pan African medical journalPubMeddocument de 11 observations

90 %Over 90% of cervical cancer-related deaths occur in low income countries.

Kenyacancer du col de l'utéruspublié 2022Frontiers in public healthPubMeddocument de 4 observations

1,2 %Three of 251 infants (1.2%) were QFT-Plus positive.

Kenyatuberculosepublié 2021The Pediatric infectious disease journalPubMeddocument de 3 observations

17,3 %Overall parasitemia positivity at enrollment in the longitudinal study was 17.3% (52/300).

Kenyapaludismepublié 2023The American journal of tropical medicine and hygienePubMeddocument de 6 observations

31 %Toluidine blue 0.05% vital staining had a specificity of 31% (95% CI, 25%–36%) for detecting ocular surface squamous neoplasia (OSSN).

Kenyaocular surface squamous neoplasia (OSSN)observé July 2012 through July 2014publié 2015JAMA ophthalmologyeurope_pmcdocument de 11 observations

34 %Thirty-four percent of adolescent girls and young women with moderate-to-severe depression had a high HIV risk score corresponding to 5 to 15 incident HIV cases per 100 person-years.

Kenyamoderate-to-severe depression · VIH/sidaobservé January to June 2019publié 2020International journal of STD & AIDSPubMeddocument de 4 observations

Less than half of individuals reported continuing PrEP at follow-up visits during the early stages of PrEP scale-up in Kenya.

KenyaVIH/sidapublié 2022PloS onePubMeddocument de 3 observations

14 %Salmonella isolates showed levels of resistance ranging from 14% to 100% in Wajir for all the antimicrobials tested.

KenyaSalmonellapublié 2019African Journal of Health SciencesOpenAlexdocument de 18 observations

0,16 hazard_ratioThose who underwent surgical management had 84% reduced hazard of mortality compared to those who were referred for other modes of care: HR: 0.16.

Kenyacancer du col de l'utéruspublié 2023BMC cancerPubMeddocument de 12 observations

Less than half of the included patients were alive 3 years after a cancer diagnosis for stomach cancer in sub-Saharan Africa.

Kenyastomach cancerpublié 2024The Lancet. Global healtheurope_pmcdocument de 12 observations

0,04 pg/μLThe mean plasma aflatoxin B1 concentration for all women living with HIV was 0.0403 pg/μL.

KenyaVIH/sidapublié 2025International journal of STD & AIDSPubMeddocument de 8 observations

18,99 daysBusia County had the longest mean DNA-PCR transport time at 18.99 days in Vihiga, Bungoma, Kakamega and Busia counties in Kenya between January 2012 and June 2013.

KenyaVIH/sidaobservé January 2012 to June 2013publié 2024PloS onePubMeddocument de 7 observations

6 175 960 USDTotal economic costs for providing HIV services to key populations were US$6,175,960 in Kenya and US$4,261,207 in Malawi for fiscal year 2019.

Kenya · MalawiVIH/sidaobservé FY2019publié 2023Global health, science and practicePubMeddocument de 4 observations

17 %In primary review results, 17% of CIN 1 cases were p16INK4a positive.

KenyaCIN 1publié 2021The Pan African medical journalPubMeddocument de 11 observations

40 %In the 2015 Kenya STEPwise Survey, individuals in Class 4 had a 40% chance of being overweight/obese.

Kenyaoverweight/obeseobservé 2015publié 2021Public healthPubMeddocument de 7 observations

60,4 %Self-reported HIV testing at 3 months was 60.4% in intervention clusters and 10.0% in control clusters.

KenyaVIH/sidapublié 2025The Lancet. Global healthPubMeddocument de 13 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.